Latest SRNE reports update at 2023-05-15: 2023-Q12022-Q42022-Q1
Sorrento Therapeutics logo

Sorrento Therapeutics SRNE

$ 0.27 -29.58%

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Henry Ji

Employees in the company

310

Shares

295 M

Market Cap[1]

$ 126 M

EBITDA (LTM)

$ -418 M

P/E (LTM)

-0.24

P/S (LTM)

3.62

EPS (LTM)

-1.12

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.